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Addition of tumour infiltration depth and extranodal extension improves the prognostic
value of the pathological TNM classification for early-stage oral squamous cell carcinoma.
Aims: In the 8th edition of the American Joint Com-
mittee on Cancer TNM staging manual, tumour infil-
tration depth and extranodal extension are added to
the pathological classification for oral squamous cell
carcinoma. The currently available 8th TNM valida-
tion studies lack patients with conservative neck
treatment, and changes in the classification especially
affect patients with small tumours. The aim of this
study was to determine the potential impact of the
changes in the 8th edition pTNM classification on the
prognosis and treatment strategy for oral squamous
cell carcinoma in a well-defined series of pT1–T2
patients with long-term follow-up.
Methods and results: Two hundred and eleven first
primary pT1–T2 oral squamous cell carcinoma
patients, with surgical resection as primary treat-
ment, were analysed retrospectively. One hundred
and seventy-three patients underwent a neck
dissection, and 38 patients had frequent clinical neck
assessments. Long-term follow-up (median
64 months) and reassessed tumour infiltration depth
were available. Classification according to the 8th edi-
tion criteria resulted in 36% total upstaging with the
T classification and 16% total upstaging with the N
classification. T3-restaged patients (n = 30, 14%) had
lower 5-year disease-specific survival rates than T2-
staged patients (81% versus 67%, P = 0.042). Post-
operative (chemo)radiotherapy could have been con-
sidered in another seven (3%) patients on the basis of
the 8th edition criteria.
Conclusions: Addition of tumour infiltration depth
and extranodal extension in the 8th TNM classifica-
tion leads to the identification of oral squamous cell
carcinoma patients with a worse prognosis who
might benefit from an improved postoperative treat-
ment strategy.
Keywords: head and neck cancer, lymph nodes, mouth neoplasms, oral cancer, survival, TNM staging
Introduction
In 2016, the 8th edition of the American Joint Com-
mittee on Cancer (AJCC) TNM staging manual was
released.1 As compared with the 7th edition, tumour
infiltration depth and extranodal extension (ENE)
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were incorporated into the pathological TNM classifi-
cation for oral squamous cell carcinoma (OSCC).1,2
On the basis of the 8th edition criteria, 7th edition
pT1 patients with a tumour infiltration depth
between 5 and 10 mm are restaged as pT2, and all
pT1 and pT2 patients with a tumour infiltration
depth of >10 mm are restaged as pT3. Following the
pN classification in the 8th edition, cases with a sin-
gle positive lymph node <30 mm in diameter with
ENE are restaged from pN1 to pN2b, and all other
ENE-positive patients are restaged as pN3b.
The incorporation of tumour infiltration depth and
ENE in the pathological TNM classification was based
on data from both the International Consortium for
Outcome Research in Head and Neck Cancer (ICOR)
(n = 3149) and the National Cancer Data Base
(n = 7264).2,3 The 8th edition has been validated in
various independent databases: the pT and pN classi-
fications by Lydiatt et al.2 (n = 1792) and Matos
et al.4 (n = 298), and the pN classification by Garcia
et al.5 (n = 1137). These studies confirmed a better
prediction of survival per stratification with the 8th
pTNM classification edition, whereby patients who
had been upstaged because of the incorporation of
tumour infiltration depth and ENE generally had
lower survival rates.
Despite the validation with big data, the clinical
impact for small tumours (pT1–T2) is not really clear.
As mentioned by Matos et al.3,4 and the ICOR study,
their populations were limited to patients undergoing
neck dissections. Patients with a clinically negative
neck not treated with selective neck dissections—also
known as watchful waiting—were not included. This
point is important, because incorporation of infiltra-
tion depth in the pT classification could also influence
prognosis and, as a result, change the treatment
strategy for these early-stage patients. Therefore, our
aim was to study the clinical impact of the 8th edi-
tion pTNM classification on the survival of 7th edi-
tion pT1–T2 patients treated with surgical resection
of the tumour combined with neck dissection or a
watchful waiting strategy. We selected pathologically
staged T1–T2 OSCC patients from our large and
homogeneous database with extensive clinicopatho-
logical and long-term follow-up data.6,7
Materials and methods
P A T I E N T S
This cohort with reassessed tumour infiltration depth
has been previously described.6,7 Briefly, 246 consec-
utive patients with pT1–T2 OSCC according to the
7th edition, diagnosed between 1997 and 2008 with
a first primary tumour and treated with surgical
resection of the tumour at the University Medical
Centre Groningen, were selected from our database.
Thirty-five patients were excluded because of multiple
head and neck tumours (n = 3), irretrievable haema-
toxylin and eosin (H&E) slides (n = 13), or unreliable
assessment of infiltration depth because of missing
epithelial surfaces and tangential tissue cutting
(n = 19), resulting in 211 patients being available for
tumour infiltration depth reassessment. Thirty-eight
patients (18%) with a pT1 tumour did not undergo a
neck dissection, but were followed closely (watchful
waiting). This strategy was common in the era before
the awareness that an infiltration depth of 4 mm
implied a high chance of tumour spread to lymph
nodes.6 The 38 patients with watchful waiting had a
median tumour infiltration depth of 3.2 mm [in-
terquartile range (IQR) 2.1–5.6 mm]. In total, 211
patients were used for analysis, and 173 of these
were treated with neck dissection. The clinical and
histopathological characteristics of the study group
are shown in Table 1. In total, 72 patients received
postoperative radiotherapy, but none of the watchful
waiting patients were postoperatively irradiated. The
median follow-up time was 64 months (range 0–
193 months). Thirteen patients (6%) were diagnosed
with local recurrence and 26 (12%) with regional
recurrence. Of the 38 watchful waiting patients, two
patients were diagnosed with a local recurrence and
seven patients with regional recurrences during their
follow-up. Sixty-eight patients (32%) died in the first
5 years after treatment, 57% because of the OSCC.
OSCC-related death (median 63 years; IQR 54–
70 years) occurred at a significantly younger age
than OSCC-unrelated death (median 71 years; IQR
62–79 years) (P = 0.010).
D A T A C O L L E C T I O N
Clinical and pathological data were collected retro-
spectively from the patient files. Tumour H&E-stained
slides were revised by one dedicated head and neck
pathologist, and tumour infiltration depth was reas-
sessed by the use of digital microscopy and comput-
erised measurements (RESEARCH ASSISTANT 6; RVC,
Soest, The Netherlands). Tumour infiltration depth
was measured from the mucosal surface or from the
reconstructed mucosal surface in cases of ulcerated or
exophytic tumours7; this differs from the AJCC man-
ual in using the mucosal surface instead of the muco-
sal basement membrane.2 ENE was defined as an
extension of tumour cells beyond the nodal capsule,
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and forms part of the standard pathology report in
our centre. Cases with no convincing extension
beyond the nodal capsule (i.e. no stromal reaction)
were scored as negative. We revised the pathological
tumour and pathological nodal classification accord-
ing to the 8th edition. Five-year disease-specific sur-
vival (DSS) was defined as the time from first
treatment until disease-specific death or the last fol-
low-up, with a maximum of 5 years. Three-year dis-
ease-free survival (DFS) was defined as the time until
local, regional or distant recurrence or the last fol-
low-up within 3 years after the start of the initial
treatment. Death was censored and did not count as
a DFS event.
E T H I C A L J U S T I F I C A T I O N
As this study used retrospectively evaluated data from
patients treated according to the Dutch national
guidelines for oral cavity cancer, approval from the
hospital research ethics board was not necessary
according to the Dutch ethical regulations.8
S T A T I S T I C S
Categorical data are presented as number and per-
centage, normally distributed data are presented as
mean with standard deviation (SD), and skewed data
are presented as median with IQR. Fisher’s exact or
chi-squared tests were used to test the associations
between categorical data. The log-rank test was used
to analyse differences between the Kaplan–Meier
curves. DSS is reported as a percentage of survival
after 5 years, and DFS is reported as a percentage of
survival after 3 years. STATA statistical software
(Release 15.1) was used to determine the 95% confi-
dence intervals of the DSS and DFS survival percent-
ages (Stata Corp., College Station, TX, USA). All other
statistical analyses were performed with IBM SPSS STATIS-
TICS 23 (SPSS, Chicago, IL, USA). P-values of <0.05
Table 1. Population characteristics
Variables Value




Age at diagnosis (years)





Floor of mouth 64 (30)
Cheek mucosa 7 (3)
Retromolar area 12 (6)
Other 6 (3)
cT status (7th edition), n (%)
1–2 189 (90)
3–4 22 (10)





Median (IQR) 6.0 (3.3–9.0)
Range 0.1–20.0
Perineural invasion, n (%) 35 (17)
Lymphovascular invasion, n (%) 19 (9)
Involved margins (<1 mm) 32 (15)
PO(C)RT, n (%) 72 (34)
Follow-up (months)
Median (IQR) 64 (30–99)
Range 0–193
Recurrences, n (%)
Locoregional recurrence 13 (6)
Regional recurrence 26 (12)
Table 1. (Continued)
Variables Value
Distant metastasis 6 (3)
Death, n (%)
Due to disease 36 (17)
Overall 68 (32)
IQR, interquartile range; PO(C)RT, postoperative chemotherapy or
radiation therapy; SD, standard deviation.
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were considered to be significant for all of the statisti-
cal analyses.
Results
T U M O U R S T A G I N G
In total, 211 patients with a median tumour infiltra-
tion depth of 6.0 mm (IQR 3.3–9.9 mm) were used
for the pT classification analysis. Tumour restaging
according to the 8th edition resulted in upstaging of
75 (36%) of the 211 patients: 12 (6%) patients on
the basis of both tumour infiltration depth and ENE,
and 63 (30%) patients on the basis of tumour infiltra-
tion depth only. Figure 1A shows the differences
between the 7th and 8th pT editions. Fifty-four pT1
patients (44%) and 21 pT2 patients (24%) were
restaged according to the 8th edition criteria. Patients
with tongue tumours were significantly more often
restaged to pT2 (31%) or pT3 (19%) than patients
with tumours in the other anatomical locations, for
whom restaging occurred in 12% (pT2) and 9%
(pT3) (P < 0.001). Of the 38 watchful waiting
patients, 11 (29%) were restaged to pT2. These
patients had significantly shorter DSS (P = 0.016)
and DFS (P = 0.033) than the other 27 patients (Fig-
ure 2A, B). Within the watchful waiting group, three
(11%) of the 27 non-restaged patients and four
(36%) of the 11 restaged patients were diagnosed
with regional recurrences during follow-up (not sig-
nificant). Sixteen of the 45 patients (35%) restaged
from pT1 to pT2 had undergone postoperative radio-
therapy after surgical resection of the tumour.
Twenty-three of the 30 patients restaged as pT3 had
been postoperatively irradiated. The 8th edition pT
classification showed good stratification, with signifi-
cantly shorter DSS for the pT1–T2 patients upstaged
to pT3 than for non-restaged pT2 patients (81% ver-
sus 66%, P = 0.048; Figure 3B; Table 2).
N O D A L S T A G I N G
Of the 173 neck dissection patients, 72 (42%) were
diagnosed with nodal metastasis. Twenty-eight (16%)
of these 173 patients were restaged with the 8th edi-
tion criteria because of ENEs (Figure 1B). No signifi-
cant differences were seen in N status restaging
between anatomical locations. Twenty-six of the 28
restaged patients had been treated postoperatively
with radiotherapy, which was combined with
chemotherapy in one patient. The 8th edition pN
classification showed good stratification, with an 89%
5-year survival rate for the watchful waiting patients,
and pN3-staged patients having the shortest survival
rates, although the difference in DSS between pN2-
staged and pN3-staged patients was not significant
(69% versus 48%, P = 0.072; Figure 3D; Table 2).
S T A G E G R O U P I N G
In total, 42 (20%) patients were restaged with the 8th
edition criteria. Differences in stage grouping per cate-
gory between the 7th and 8th editions are shown in
Figure 1C. Restaging with the 8th edition resulted in a
smaller difference in DSS between stage I and stage II:











































































Figure 1. Differences in tumour, nodal and stage grouping between
the 7th and 8th editions of the American Joint Committee on Can-
cer TNM classification. N, nodal; ND, neck dissection; T, tumour;
WW, watchful waiting.
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the 7th and 8th stage I and stage II editions, respec-
tively. After restaging with the 8th edition criteria, the
difference in DSS was larger between stage II and stage
III, being 12% with the 7th edition (85% and 73%, not
significant) versus 20% with the 8th edition (94% and
74%, P = 0.007) (Figure 3F; Table 2).
Discussion
The aim of this study was to determine the clinical
impact of the addition of tumour infiltration depth and
ENE in the 8th edition of the pathological TNM classifi-
cation on survival and potential alterations in treat-
ment strategy for pT1–T2 OSCC patients who had been
treated on the basis of the 7th edition. In this study,
36% and 16% of all of the patients were restaged with
the 8th edition criteria according to the pT and pN
classifications, respectively. Patients restaged as pT3
showed significantly shorter DSS than 8th edition
pT1–T2-staged patients. Another seven (3%) patients
who were restaged as pT3 could possibly have bene-
fited from postoperative radiotherapy.
This study used a well-defined 7th edition pT1–T2
cohort with extensive clinical data to add to the cur-
rent evidence validating the 8th edition TNM classifi-
cation.2,4,5 Patients with a watchful waiting strategy
of the neck were also included, which was not the case
in the large ICOR study and the validation study by
Matos et al.3,4 Recently, two other studies investigated
the differences between the 7th edition and 8th edition
TNM staging by using early-stage OSCC patients.9,10
These studies differed from the current study by using
sentinel lymph node biopsy (SLNB)-staged patients or
by analysing only the pT categories and not the pN
categories. This study confirms the previously men-
tioned validation study findings regarding the shorter
survival rate of patients restaged as pT3 and pN3 with
the 8th edition criteria.2,4,5 However, the number of
restaged patients differs between studies. In this study,
44% of the 7th edition pT1 patients were restaged, ver-
sus 44% and 61% in other studies,3,4 and 24% of the
pT2 patients were restaged, versus 62% and 47% in
other studies.3,4 Remarkably, one of the other studies
did not restage any of the 7th edition pT1 patients to
pT3.3 Differences in restaging rates might be explained
by differences in clinical care between the countries. In
The Netherlands, people visit their general dental prac-
titioner once a year or more, whereas one of the vali-
dation studies stated in the discussion that the
restaging rates could have been limited by a high rate
of advanced disease, which is a reality in emerging
countries.4
Restaging to a higher classification level with the
8th edition criteria is only possible for 7th edition
pT1–T2 patients. Consequently, the 8th edition is
clinically most relevant for these patients. This is why
we used a cohort of 7th edition pT1–T2 patients to
obtain an unadulterated view of the differences in
prognosis. The inclusion of only pT1–T2 patients
resulted in a relatively small number of 8th edition
pT3 patients as compared with other studies. Also,
the ENE rate in this study is lower than in the other
8th edition TNM validation studies: 39% versus 51%
and 53%, respectively.4,5 The inclusion of only pT1–
T2 patients could explain the lower ENE rate than in
studies that also included more advanced disease.
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Figure 2. Differences in disease-specific survival (A) and disease-free survival (B) for 7th pT1-classified patients with a watchful waiting strat-
egy of the neck which were staged using the 8th edition pT criteria
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Figure 3. Disease-specific survival (DSS) Kaplan–Meier curves for the 7th edition (A,C,E) and the 8th edition (B,D,F) American Joint Commit-
tee on Cancer TNM classifications. Five-year survival rates with their 95% confidence intervals for each disease-specific survival curve and
log-rank test are given in Table 2. N, nodal; T, tumour; WW, watchful waiting.
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We previously stated that a tumour infiltration
depth of 4 mm could serve as an optimal cut-off
between elective and therapeutic neck dissections, on
the basis of results obtained with the same cohort.6
Therefore, it is not surprising that the 8th edition
pT2 patients (tumour infiltration depth of 5–10 mm)
showed shorter survival in this study. Furthermore,
another study suggested using a 4-mm tumour infil-
tration depth as a cut-off for pT3 tumours instead of
the 8th edition AJCC pT cut-offs.9 Twelve patients in
this cohort had watchful waiting of the neck and an
infiltration depth of >4 mm, because they were trea-
ted before the introduction of the 4-mm cut-off in our
centre. Exclusion of these 12 patients resulted in
100% 5-year survival for the remaining watchful
waiting patients, and similar survival stratifications
for the 7th and 8th pT and pN categories (Data S1
and S2).
Table 2. Disease-specific survival rates, 95% confidence intervals (CIs) and log-rank test results of all stages
Edition Category
Survival Log-rank test
5-year (%) 95% CI Compared groups P-value
7th pT class T1 89 82–93 T1 versus T2 0.002
T2 72 61–81
8th pT class T1 91 81–96 T1 versus T2 0.077
T2 81 72–87 T2 versus T3 0.048
T3 66 45–80 T1 versus T3 0.001
7th pN class WW 89 73–86 WW versus N0 0.734
N0 92 84–96 N0 versus N1 0.005
N1 73 54–86 N1 versus N2 0.264
N2 59 42–73 N2 versus N3 0.402
N3 0 NA
8th pN class WW 89 73–96 WW versus N0 0.734
N0 92 84–96 N0 versus N1 0.016
N1 75 53–88 N1 versus N2 0.793
N2 69 46–84 N2 versus N3 0.072
N3 48 26–67
7th SG class WW 89 73–96 WW versus stage I 0.195
Stage I 96 86–99 Stage I versus stage II 0.056
Stage II 85 70–93 Stage II versus stage III 0.184
Stage III 73 54–86 Stage III versus stage IV 0.220
Stage IV 58 40–72
8th SG class WW 89 73–96 WW versus stage I 0.270
Stage I 97 78–99 Stage I versus stage II 0.594
Stage II 94 83–98 Stage II versus stage III 0.007
Stage III 74 58–85 Stage III versus stage IV 0.167
Stage IV 59 43–72
N, nodal; SG, stage grouping; T, tumour; WW, watchful waiting.
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The benefit of this cohort was the availability of
long-term follow-up, because no adjustments were
made for OSCC in the 7th pTNM classification edition
when it was released in 2009, as compared with the
6th edition.11
Additions to the pTNM classification are useful if
they can be measured robustly and have a clinical
impact. The national guidelines in The Netherlands
support postoperative radiotherapy of T3–T4
tumours, even those with clear margins.12 If the
patients in this cohort had been staged with the 8th
edition and treated accordingly, another 3% of the
patients would have received postoperative radiother-
apy. Although the patients who were restaged
according to the 8th edition pT classification criteria
showed lower DSS, prospective studies are needed to
confirm that radiotherapy is beneficial for these
patients. Besides the adjuvant therapy, SLNB is cur-
rently used as staging technique for cT1–2N0
patients in our centre.13 This study shows that the
30 (15%) patients who were restaged as T3 would
not have had an indication for an SLNB according to
the 8th edition criteria. Den Toom et al.10 stated that
8th edition pT3 patients with tumours ≤40 mm in
diameter probably benefit from staging of the neck
with the SLNB procedure. However, further data are
needed to verify whether the SLNB is still a reliable
neck-staging technique for patients restaged from 7th
edition pT1–T2 to 8th edition pT3. In our centre,
pN3 patients are treated postoperatively with con-
comitant chemoradiotherapy according to the current
guidelines.12 Despite the better prognostic value of
the 8th edition pN classification, pN staging with the
8th edition would not alter postoperative treatment
strategies in our centre.
The growth of OSCCs can occur in an exophytic, an
ulcerative or a superficial manner.2,6 These differences
in surface growth have resulted in various methods of
assessment of tumour infiltration depth and thickness
in the past.2 To prevent underestimation (ulcerative
growth) or overestimation (exophytic growth) of the
prognosis, for the 8th pT classification tumour infiltra-
tion needs to be measured vertically from the recon-
structed mucosa by use of the adjacent mucosal
basement membrane of the normal epithelium.2 In this
study, the mucosal surface was used instead of the
basement membrane. Healthy epithelial thicknesses
are approximately 216 µm (SD 59 µm) for the tongue
and 99 µm (SD 22 µm) for the mucosa of the anterior
floor of the mouth.14 Because of these small differences
between healthy mucosal surfaces and basement mem-
branes, it is improbable that tumour infiltration depth
assessment by use of the basement membrane would
have a large impact on our data. This was confirmed
by an earlier study reporting an extremely high corre-
lation between both methods (3.7% pT category differ-
ence).4 Another study reported a 5.7% difference in pT
category when it compared both methods without cor-
recting for exophytic growth.15 In cases of metastasis
in lymph nodes, all cases with extension of the metas-
tasis through the fibrous capsule into the surrounding
tissue should be scored as ENE-positive.2 To study the
effect of ENE size in the future, Lydiatt et al.2 advocate
to divide ENE-positive lymph nodes in lymph nodes
with minor ENE (<2 mm) and major ENE (>2 mm and
metastasis without recognisable lymph node).
This study demonstrates, in a well-defined retro-
spective cohort of 211 pT1–T2 (7th edition) OSCC
patients, that the addition of tumour infiltration
depth and ENE, as used in the 8th edition of the AJCC
pathological TNM classification, identifies a group of
restaged patients with a worse prognosis.
Conflict of Interests
The authors have no conflicts of interest to declare
Author contributions
Concept, design, analysis and interpretation of data:
K. Boeve, B. A. van Dijk, E. Schuuring, J. L. Rooden-
burg, B. van der Vegt, and M. J. Witjes. Acquisition
of data: K. Boeve, L. J. Melchers, G. B. Halmos, J. L.
Roodenburg, B. van der Vegt, and M. J. Witjes. Criti-
cal revision of the manuscript: all authors. Final
approval of the version to be published: K. Boeve, E.
Schuuring, Jan L Roodenburg, B. van der Vegt, and
M. J. Witjes.
Acknowledgements
The author(s) received no specific funding for this
work.
References
1. Amin MB, Edge S, Greene F et al. AJCC cancer staging manual.
8th ed. Chicago: Springer International Publishing, 2017.
2. Lydiatt WM, Patel SG, O’Sullivan B et al. Head and neck can-
cers—major changes in the American Joint Committee on Can-
cer eighth edition cancer staging manual. CA Cancer J. Clin.
2017; 67; 122–137.
3. International Consortium for Outcome Research (ICOR) in
Head and Neck Cancer, Ebrahimi A, Gil Z et al. Primary tumor
staging for oral cancer and a proposed modification incorporat-
ing depth of invasion: an international multicenter
© 2019 The Authors. Histopathology Published by John Wiley & Sons Ltd, Histopathology, 75, 329–337.
336 K Boeve et al.
retrospective study. JAMA Otolaryngol. Head Neck Surg. 2014;
140; 1138–1148.
4. Matos LL, Dedivitis RA, Kulcsar MAV, de Mello ES, Alves VAF,
Cernea CR. External validation of the AJCC Cancer Staging
Manual, 8th edition, in an independent cohort of oral cancer
patients. Oral Oncol. 2017; 71; 47–53.
5. Garcia J, Lopez M, Lopez L et al. Validation of the pathological
classification of lymph node metastasis for head and neck
tumors according to the 8th edition of the TNM Classification
of Malignant Tumors. Oral Oncol. 2017; 70; 29–33.
6. Melchers LJ, Schuuring E, van Dijk BA et al. Tumour infiltra-
tion depth >/=4 mm is an indication for an elective neck dis-
section in pT1cN0 oral squamous cell carcinoma. Oral Oncol.
2012; 48; 337–342.
7. Heerema MG, Melchers LJ, Roodenburg JL, Schuuring E, de
Bock GH, van der Vegt B. Reproducibility and prognostic value
of pattern of invasion scoring in low-stage oral squamous cell
carcinoma. Histopathology 2016; 68; 388–397.
8. Central Dutch.Committee on Research Involving Human Sub-
jects. Available at: http://www.ccmo.nl/en/non-wmo-research
(accessed 11 August 2017).
9. Almangush A, Makitie AA, Small Makinen LK et al. Small oral
tongue cancers (</= 4 cm in diameter) with clinically negative
neck: from the 7th to the 8th edition of the American Joint
Committee on Cancer. Virchows Arch. 2018; 473; 481–487.
10. den Toom IJ, Janssen LM, van Es RJJ et al. Depth of invasion
in patients with early stage oral cancer staged by sentinel node
biopsy. Head Neck 2019; 41; 2100–2106.
11. Schmoll H-J, Greene FL, Page DL, Fleming ID et al. (eds). AJCC
Cancer Staging Manual, 6th edition. Ann. Oncol. 2003; 14;
345–346.
12. Dutch guideline head and neck cancer 2014. Available at:
https://www.nvmka.nl/sites/www.nvmka.nl/files/Richtlijn%
20Hoofd-halstumoren%202015.pdf (accessed 30 March
2017).
13. Boeve K, Schepman KP, Schuuring E et al. High sensitivity and
negative predictive value of sentinel lymph node biopsy in a
retrospective early stage oral cavity cancer cohort in the
Northern Netherlands. Clin. Otolaryngol. 2018. https://doi.org/
10.1111/his.13886. Mar 25 [Epub ahead of print].
14. Prestin S, Rothschild SI, Betz CS, Kraft M. Measurement of
epithelial thickness within the oral cavity using optical coher-
ence tomography. Head Neck 2012; 34; 1777–1781.
15. Dirven R, Ebrahimi A, Moeckelmann N, Palme CE, Gupta R,
Clark J. Tumor thickness versus depth of invasion—analysis of
the 8th edition American Joint Committee on Cancer Staging
for oral cancer. Oral Oncol. 2017; 74; 30–33.
Supporting Information
Additional Supporting Information may be found in
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Data S1. Disease-specific survival rates, 95% confi-
dence intervals and log-rank test results of all stages
after exclusion of watchful waiting patients with a
tumour infiltration depth of >4 mm.
Data S2. Disease-specific survival Kaplan-Meier
curves for the 7th edition (A,C,E) and the 8th edition
(B,D,F) TNM classifications after exclusion of watchful
waiting patients with a tumourinfiltration depth of
>4 mm.
© 2019 The Authors. Histopathology Published by John Wiley & Sons Ltd, Histopathology, 75, 329–337.
8th OSCC TNM classification prognostic value 337
